Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.
Hepatol Res
; 54(4): 382-391, 2024 Apr.
Article
in En
| MEDLINE
| ID: mdl-37983642
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Hepatol Res
Year:
2024
Type:
Article
Affiliation country:
Japan